Alzheimer's disease (AD) is an age-related, neurodegenerative disease that is one of the leading causes of dementia afflicting 1% of people under the age of 60 to more than 40% of people over the age of 85. The symptoms of this disease are typified by memory loss and a progressive decline of cognitive abilities. This disease is characterized by the extracellular deposition of amyloid-beta (Ab) aggregates known as plaques that are surrounded by dystrophic neurites and activated glial cells as well as intracellular neurofibrillary tangles that are comprised of hyperphosphorylated tau protein aggregates. As detailed in the February 2006 Alzheimer's Research Forum, one of the most critical needs in AD research is the identification of biomarkers that can not only predict disease but also monitor responses to treatment. In this project, we first propose to utilize a novel MRI methodology, Manganese Enhanced MRI (MEMRI) that we helped develop to delineate the role of AB on in vivo axonal transport rates and pre-synaptic release and post-synaptic uptake mechanisms in mouse models of AD. Second, we will test MEMRI as an in vivo neuroimaging diagnostic to assess and potentially detect very early on responses to treatment in mouse models of AD. Third, we will determine if Ab1- 40, Ab1-42 or the combination of the two species contributes to in vivo changes in axonal transport and pre- synaptic release and post-synaptic uptake mechanisms in mouse models of AD.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG029977-05
Application #
8230559
Study Section
Cell Death in Neurodegeneration Study Section (CDIN)
Program Officer
Refolo, Lorenzo
Project Start
2008-03-15
Project End
2014-02-28
Budget Start
2012-03-01
Budget End
2014-02-28
Support Year
5
Fiscal Year
2012
Total Cost
$299,442
Indirect Cost
$104,366
Name
Baylor College of Medicine
Department
Physiology
Type
Schools of Medicine
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Killoran, Kristin E; Miller, Amber D; Uray, Karen S et al. (2014) Role of innate immunity and altered intestinal motility in LPS- and MnCl2-induced intestinal intussusception in mice. Am J Physiol Gastrointest Liver Physiol 306:G445-53
Holth, Jerrah K; Bomben, Valerie C; Reed, J Graham et al. (2013) Tau loss attenuates neuronal network hyperexcitability in mouse and Drosophila genetic models of epilepsy. J Neurosci 33:1651-9
Ma, Tao; Hoeffer, Charles A; Wong, Helen et al. (2011) Amyloid ýý-induced impairments in hippocampal synaptic plasticity are rescued by decreasing mitochondrial superoxide. J Neurosci 31:5589-95
Massaad, Cynthia A; Pautler, Robia G (2011) Manganese-enhanced magnetic resonance imaging (MEMRI). Methods Mol Biol 711:145-74
Smith, Karen D B; Paylor, Richard; Pautler, Robia G (2011) R-flurbiprofen improves axonal transport in the Tg2576 mouse model of Alzheimer's disease as determined by MEMRI. Magn Reson Med 65:1423-9
Inoue, Taeko; Majid, Tabassum; Pautler, Robia G (2011) Manganese enhanced MRI (MEMRI): neurophysiological applications. Rev Neurosci 22:675-94
Smith, Karen D B; Peethumnongsin, Erica; Lin, Han et al. (2010) Increased Human Wildtype Tau Attenuates Axonal Transport Deficits Caused by Loss of APP in Mouse Models. Magn Reson Insights 4:11-18
Sharma, Ruchi; Buras, Eric; Terashima, Tomoya et al. (2010) Hyperglycemia induces oxidative stress and impairs axonal transport rates in mice. PLoS One 5:e13463
Massaad, Cynthia A; Amin, Samir K; Hu, Lingyun et al. (2010) Mitochondrial superoxide contributes to blood flow and axonal transport deficits in the Tg2576 mouse model of Alzheimer's disease. PLoS One 5:e10561
Peethumnongsin, Erica; Yang, Li; Kallhoff-Munoz, Verena et al. (2010) Convergence of presenilin- and tau-mediated pathways on axonal trafficking and neuronal function. J Neurosci 30:13409-18

Showing the most recent 10 out of 15 publications